Cyclosporin-containing pharmaceutical compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424451, 530317, A61K 3800, A61K 948

Patent

active

059588764

ABSTRACT:
The present invention relates to a cyclosporin-containing soft capsule preparation which contains a composition containing cyclosporin as an active ingredient; a non-hydrophilic component propylene carbonate or a mixture of propylene carbonate and a hydrophilic component polyethylene glycol, one or a mixture of two or more selected from the group consisting of an esterified compound of fatty acid and primary alcohol, medium chain fatty acid triglyceride and fatty acid monoglyceride as an oil component; and a surfactant having an HLB (Hydrophilic Lipophilic Balance) value of 8 to 17.

REFERENCES:
patent: 4388307 (1983-06-01), Cavanak
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5589455 (1996-12-01), Woo
patent: 5626872 (1997-05-01), Vasquez
Wade et al., Handbook of Pharmaceutical Excipients (1994), pp. 355-361, 648.
Ainley Wade and Paul J. Weller, (eds.), Handbook of Pharmaceutical Excipients, 2nd ed., "Propylene Carbonate," pp. 405-406.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclosporin-containing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclosporin-containing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin-containing pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-703190

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.